05:58 PM EDT, 09/03/2025 (MT Newswires) -- Jonathan Allan, General Counsel and Corporate Secretary, on August 29, 2025, sold 22,117 shares in Stoke Therapeutics ( STOK ) for $444,809. Following the Form 4 filing with the SEC, Allan has control over a total of 11,831 common shares of the company, with 11,831 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1623526/000141588925023589/xslF345X05/form4-09032025_090917.xml